Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Postprandial decrease in LDL-cholesterol in men with metabolic syndrome.

Open medicine (Warsaw, Poland)

Skoczyńska A, Turczyn B, Wojakowska A, Kreczyńska B, Skoczyńska M, Wojtas K.
PMID: 28352689
Open Med (Wars). 2015 Feb 03;10(1):138-151. doi: 10.1515/med-2015-0025. eCollection 2015.

BACKGROUND: In some epidemiological studies, blood lipids are determined at non-fasting state, which may impact cardiovascular risk estimation. The aim of this study was to evaluate postprandial LDL-C changes in men with newly diagnosed metabolic syndrome (MetSy).METHODS: 36 male...

Cite
Skoczyńska A, Turczyn B, Wojakowska A, et al. Postprandial decrease in LDL-cholesterol in men with metabolic syndrome. Open Med (Wars). 2015;10(1):138-151doi: 10.1515/med-2015-0025.
Skoczyńska, A., Turczyn, B., Wojakowska, A., Kreczyńska, B., Skoczyńska, M., & Wojtas, K. (2015). Postprandial decrease in LDL-cholesterol in men with metabolic syndrome. Open medicine (Warsaw, Poland), 10(1), 138-151. https://doi.org/10.1515/med-2015-0025
Skoczyńska, Anna, et al. "Postprandial decrease in LDL-cholesterol in men with metabolic syndrome." Open medicine (Warsaw, Poland) vol. 10,1 (2015): 138-151. doi: https://doi.org/10.1515/med-2015-0025
Skoczyńska A, Turczyn B, Wojakowska A, Kreczyńska B, Skoczyńska M, Wojtas K. Postprandial decrease in LDL-cholesterol in men with metabolic syndrome. Open Med (Wars). 2015 Feb 03;10(1):138-151. doi: 10.1515/med-2015-0025. eCollection 2015. PMID: 28352689; PMCID: PMC5153088.
Copy Download .nbib Format: NLM
Relation between low serum cholesteryl-ester transfer activity and abdominal aortic calcification in normolipidemic elderly subjects.

Archives of gerontology and geriatrics

Miyashita Y, Morimoto S, Fukuo K, Masuyama T, Yasuda O, Koh E, Tamatani M, Nakahashi T, Ogihara T.
PMID: 15374350
Arch Gerontol Geriatr. 1993 Jan-Feb;16(1):9-15. doi: 10.1016/0167-4943(93)90022-a.

We studied the relation between cholesteryl-ester transfer activity (CETA) and abdominal aortic calcification in elderly subjects. Compared with 10 young healthy subjects (mean +/- S.D. age, 27 +/-2 years) and to 26 elderly subjects without abdominal aortic calcification (79...

Cite
Miyashita Y, Morimoto S, Fukuo K, et al. Relation between low serum cholesteryl-ester transfer activity and abdominal aortic calcification in normolipidemic elderly subjects. Arch Gerontol Geriatr. 1993;16(1):9-15doi: 10.1016/0167-4943(93)90022-a.
Miyashita, Y., Morimoto, S., Fukuo, K., Masuyama, T., Yasuda, O., Koh, E., Tamatani, M., Nakahashi, T., & Ogihara, T. (1993). Relation between low serum cholesteryl-ester transfer activity and abdominal aortic calcification in normolipidemic elderly subjects. Archives of gerontology and geriatrics, 16(1), 9-15. https://doi.org/10.1016/0167-4943(93)90022-a
Miyashita, Y, et al. "Relation between low serum cholesteryl-ester transfer activity and abdominal aortic calcification in normolipidemic elderly subjects." Archives of gerontology and geriatrics vol. 16,1 (1993): 9-15. doi: https://doi.org/10.1016/0167-4943(93)90022-a
Miyashita Y, Morimoto S, Fukuo K, Masuyama T, Yasuda O, Koh E, Tamatani M, Nakahashi T, Ogihara T. Relation between low serum cholesteryl-ester transfer activity and abdominal aortic calcification in normolipidemic elderly subjects. Arch Gerontol Geriatr. 1993 Jan-Feb;16(1):9-15. doi: 10.1016/0167-4943(93)90022-a. PMID: 15374350.
Copy Download .nbib Format: NLM
Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications.

The open biochemistry journal

Nascimento H, Costa E, Rocha-Pereira P, Rego C, Mansilha HF, Quintanilha A, Santos-Silva A, Belo L.
PMID: 22629286
Open Biochem J. 2012;6:43-50. doi: 10.2174/1874091X01206010043. Epub 2012 May 11.

OBJECTIVES: Evaluate cardiovascular risk factors in Portuguese obese children and adolescents and the long-term effects of lifestyle modifications on such risk factors.DESIGN: Transversal cohort study and longitudinal study.SETTING: University Hospital S. João and Children's Hospital Maria Pia, Porto.PATIENTS/PARTICIPANTS: 148...

Cite
Nascimento H, Costa E, Rocha-Pereira P, et al. Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J. 2012;6:43-50doi: 10.2174/1874091X01206010043.
Nascimento, H., Costa, E., Rocha-Pereira, P., Rego, C., Mansilha, H. F., Quintanilha, A., Santos-Silva, A., & Belo, L. (2012). Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. The open biochemistry journal, 643-50. https://doi.org/10.2174/1874091X01206010043
Nascimento, Henrique, et al. "Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications." The open biochemistry journal vol. 6 (2012): 43-50. doi: https://doi.org/10.2174/1874091X01206010043
Nascimento H, Costa E, Rocha-Pereira P, Rego C, Mansilha HF, Quintanilha A, Santos-Silva A, Belo L. Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J. 2012;6:43-50. doi: 10.2174/1874091X01206010043. Epub 2012 May 11. PMID: 22629286; PMCID: PMC3358715.
Copy Download .nbib Format: NLM
Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'.

Legal medicine (Tokyo, Japan)

Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K.
PMID: 12935528
Leg Med (Tokyo). 2001 Jun;3(2):84-94. doi: 10.1016/s1344-6223(01)00010-4.

In our recent report, it remained unclear whether or not triglyceride-rich lipoprotein remnants (RLP) were associated with the risk of sudden coronary death in younger cases without coronary atherosclerosis that were detected in about 10% of all sudden coronary...

Cite
Takeichi S, Nakajima Y, Yukawa N, et al. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med (Tokyo). 2001;3(2):84-94doi: 10.1016/s1344-6223(01)00010-4.
Takeichi, S., Nakajima, Y., Yukawa, N., Saito, T., Seto, Y., Huang, X. L., Kusakabe, T., Jin, Z. B., Hasegawa, I., Nakano, T., Saniabadi, A., Adachi, M., Ohara, N., Wang, T., & Nakajima, K. (2001). Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Legal medicine (Tokyo, Japan), 3(2), 84-94. https://doi.org/10.1016/s1344-6223(01)00010-4
Takeichi, S, et al. "Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'." Legal medicine (Tokyo, Japan) vol. 3,2 (2001): 84-94. doi: https://doi.org/10.1016/s1344-6223(01)00010-4
Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med (Tokyo). 2001 Jun;3(2):84-94. doi: 10.1016/s1344-6223(01)00010-4. PMID: 12935528.
Copy Download .nbib Format: NLM
APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population.

The Journal of the Association of Physicians of India

Modi R, Kothiwale VA, Patted S, Halkati PC.
PMID: 31556268
J Assoc Physicians India. 2017 Oct;65(12):22-27.

BACKGROUND: Abnormal lipids are an important risk factor for development of Coronary Artery Disease, significant patients have normal lipid profile and yet develop CAD. Apolipoproteins B, Apolipoproteins A and their ratio have been shown to be better predictor of...

Cite
Modi R, Kothiwale VA, Patted S, et al. APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. J Assoc Physicians India. 2017;65(12):22-27
Modi, R., Kothiwale, V. A., Patted, S., & Halkati, P. C. (2017). APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. The Journal of the Association of Physicians of India, 65(12), 22-27.
Modi, Ranjan, et al. "APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population." The Journal of the Association of Physicians of India vol. 65,12 (2017): 22-27.
Modi R, Kothiwale VA, Patted S, Halkati PC. APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. J Assoc Physicians India. 2017 Oct;65(12):22-27. PMID: 31556268.
Copy Download .nbib Format: NLM
Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea.

The open cardiovascular medicine journal

Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E, Bouros D.
PMID: 22216063
Open Cardiovasc Med J. 2011;5:231-8. doi: 10.2174/1874192401105010231. Epub 2011 Dec 26.

Obstructive Sleep Apnoea (OSA) is a common disorder in adults. Its hallmark is repetitive episodes of partial or complete obstruction of the upper airway during sleep associated with increasing respiratory efforts. This leads to oxyhaemoglobin desaturation, sleep fragmentation, and...

Cite
Michailidis V, Steiropoulos P, Nena E, et al. Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J. 2011;5:231-8doi: 10.2174/1874192401105010231.
Michailidis, V., Steiropoulos, P., Nena, E., Papanas, N., Maltezos, E., & Bouros, D. (2011). Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. The open cardiovascular medicine journal, 5231-8. https://doi.org/10.2174/1874192401105010231
Michailidis, Vassileios, et al. "Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea." The open cardiovascular medicine journal vol. 5 (2011): 231-8. doi: https://doi.org/10.2174/1874192401105010231
Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E, Bouros D. Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J. 2011;5:231-8. doi: 10.2174/1874192401105010231. Epub 2011 Dec 26. PMID: 22216063; PMCID: PMC3249661.
Copy Download .nbib Format: NLM
Atherogenesis Insights from the study of transgenic and gene-targeted mice.

Trends in cardiovascular medicine

Stoltzfus L, Rubin EM.
PMID: 21244939
Trends Cardiovasc Med. 1993 Jul-Aug;3(4):130-4. doi: 10.1016/1050-1738(93)90013-V.

Owing to the investigative power of classical mouse genetics and the development of transgenic and gene-targeting technologies, the mouse has increasingly been used to study atherogenesis. Investigators have manipulated the plasma levels of several proteins involved in lipid metabolism...

Cite
Stoltzfus L, Rubin EM. Atherogenesis Insights from the study of transgenic and gene-targeted mice. Trends Cardiovasc Med. 1993;3(4):130-4doi: 10.1016/1050-1738(93)90013-V.
Stoltzfus, L., & Rubin, E. M. (1993). Atherogenesis Insights from the study of transgenic and gene-targeted mice. Trends in cardiovascular medicine, 3(4), 130-4. https://doi.org/10.1016/1050-1738(93)90013-V
Stoltzfus, L, and Rubin, E M. "Atherogenesis Insights from the study of transgenic and gene-targeted mice." Trends in cardiovascular medicine vol. 3,4 (1993): 130-4. doi: https://doi.org/10.1016/1050-1738(93)90013-V
Stoltzfus L, Rubin EM. Atherogenesis Insights from the study of transgenic and gene-targeted mice. Trends Cardiovasc Med. 1993 Jul-Aug;3(4):130-4. doi: 10.1016/1050-1738(93)90013-V. PMID: 21244939.
Copy Download .nbib Format: NLM
Rosiglitazone and fenofibrate additive effects on lipids.

Cholesterol

Slim A, Castillo-Rojas L, Hulten E, Slim JN, Pearce Moore D, Villines TC.
PMID: 22162805
Cholesterol. 2011;2011:286875. doi: 10.1155/2011/286875. Epub 2011 Nov 24.

Background. To evaluate the effect of rosiglitazone, fenofibrate, or their combined use on plasma lipids in normoglycemic healthy adults. Methods and Results. Subjects were randomized in a double-blind fashion to rosiglitazone + placebo, fenofibrate + placebo, rosiglitazone + fenofibrate,...

Cite
Slim A, Castillo-Rojas L, Hulten E, et al. Rosiglitazone and fenofibrate additive effects on lipids. Cholesterol. 2011;2011:286875doi: 10.1155/2011/286875.
Slim, A., Castillo-Rojas, L., Hulten, E., Slim, J. N., Pearce Moore, D., & Villines, T. C. (2011). Rosiglitazone and fenofibrate additive effects on lipids. Cholesterol, 2011286875. https://doi.org/10.1155/2011/286875
Slim, Ahmad, et al. "Rosiglitazone and fenofibrate additive effects on lipids." Cholesterol vol. 2011 (2011): 286875. doi: https://doi.org/10.1155/2011/286875
Slim A, Castillo-Rojas L, Hulten E, Slim JN, Pearce Moore D, Villines TC. Rosiglitazone and fenofibrate additive effects on lipids. Cholesterol. 2011;2011:286875. doi: 10.1155/2011/286875. Epub 2011 Nov 24. PMID: 22162805; PMCID: PMC3227227.
Copy Download .nbib Format: NLM
The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons.

Archives of medical science : AMS

Wysocka E, Cymerys M, Mielcarz G, Bryl W, Dzięgielewska S, Torliński L.
PMID: 22291765
Arch Med Sci. 2011 Apr;7(2):257-63. doi: 10.5114/aoms.2011.22076. Epub 2011 May 17.

INTRODUCTION: Obesity-related disturbances are considered to be risk factors for cardiovascular disease (CVD). Chromium is shown to improve carbohydrate and lipid metabolism. Conflicting data on effects of chromium supplementation in humans are published. The aim of the study was...

Cite
Wysocka E, Cymerys M, Mielcarz G, et al. The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Arch Med Sci. 2011;7(2):257-63doi: 10.5114/aoms.2011.22076.
Wysocka, E., Cymerys, M., Mielcarz, G., Bryl, W., Dzięgielewska, S., & Torliński, L. (2011). The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Archives of medical science : AMS, 7(2), 257-63. https://doi.org/10.5114/aoms.2011.22076
Wysocka, Ewa, et al. "The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons." Archives of medical science : AMS vol. 7,2 (2011): 257-63. doi: https://doi.org/10.5114/aoms.2011.22076
Wysocka E, Cymerys M, Mielcarz G, Bryl W, Dzięgielewska S, Torliński L. The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Arch Med Sci. 2011 Apr;7(2):257-63. doi: 10.5114/aoms.2011.22076. Epub 2011 May 17. PMID: 22291765; PMCID: PMC3258713.
Copy Download .nbib Format: NLM
In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism.

Obstetrics and gynecology international

Matos A, Pereira da Silva A, Clara Bicho M, Afonso C, Areias MJ, Rebelo I, Bicho M.
PMID: 25101128
Obstet Gynecol Int. 2014;2014:361727. doi: 10.1155/2014/361727. Epub 2014 Jul 02.

Preeclampsia (PE) may affect the risk for future cardiovascular disease. Haptoglobin (Hp), an acute phase protein with functional genetic polymorphism, synthesized in the hepatocyte and in many peripheral tissues secondary of oxidative stress of PE, may modulate that risk...

Cite
Matos A, Pereira da Silva A, Clara Bicho M, et al. In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism. Obstet Gynecol Int. 2014;2014:361727doi: 10.1155/2014/361727.
Matos, A., Pereira da Silva, A., Clara Bicho, M., Afonso, C., Areias, M. J., Rebelo, I., & Bicho, M. (2014). In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism. Obstetrics and gynecology international, 2014361727. https://doi.org/10.1155/2014/361727
Matos, Andreia, et al. "In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism." Obstetrics and gynecology international vol. 2014 (2014): 361727. doi: https://doi.org/10.1155/2014/361727
Matos A, Pereira da Silva A, Clara Bicho M, Afonso C, Areias MJ, Rebelo I, Bicho M. In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism. Obstet Gynecol Int. 2014;2014:361727. doi: 10.1155/2014/361727. Epub 2014 Jul 02. PMID: 25101128; PMCID: PMC4102073.
Copy Download .nbib Format: NLM
International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B.

The Journal of automatic chemistry

Marcovina S, Curtiss LK, Milne R, Albers JJ.
PMID: 18925274
J Automat Chem. 1990;12(5):195-8. doi: 10.1155/S1463924690000256.

No abstract available.

Cite
Marcovina S, Curtiss LK, Milne R, et al. International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. J Automat Chem. 1990;12(5):195-8doi: 10.1155/S1463924690000256.
Marcovina, S., Curtiss, L. K., Milne, R., & Albers, J. J. (1990). International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. The Journal of automatic chemistry, 12(5), 195-8. https://doi.org/10.1155/S1463924690000256
Marcovina, S, et al. "International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B." The Journal of automatic chemistry vol. 12,5 (1990): 195-8. doi: https://doi.org/10.1155/S1463924690000256
Marcovina S, Curtiss LK, Milne R, Albers JJ. International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. J Automat Chem. 1990;12(5):195-8. doi: 10.1155/S1463924690000256. PMID: 18925274; PMCID: PMC2547832.
Copy Download .nbib Format: NLM
Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction.

Annals of Saudi medicine

Al-Muhtaseb N, Al-Yousuf AR.
PMID: 17589176
Ann Saudi Med. 1992 May;12(3):252-8. doi: 10.5144/0256-4947.1992.252.

Plasm levels of lipid, lipoprotein, and apolipoprotein (APO) A-I, A-II, C-II, C-III, and E were analyzed in 180 young survivors of myocardial infarction (MI) ages 28 to 45 years and in 200 sex-and age-matched normal healthy subjects to assess...

Cite
Al-Muhtaseb N, Al-Yousuf AR. Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Ann Saudi Med. 1992;12(3):252-8doi: 10.5144/0256-4947.1992.252.
Al-Muhtaseb, N., & Al-Yousuf, A. R. (1992). Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Annals of Saudi medicine, 12(3), 252-8. https://doi.org/10.5144/0256-4947.1992.252
Al-Muhtaseb, N, and Al-Yousuf, A R. "Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction." Annals of Saudi medicine vol. 12,3 (1992): 252-8. doi: https://doi.org/10.5144/0256-4947.1992.252
Al-Muhtaseb N, Al-Yousuf AR. Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Ann Saudi Med. 1992 May;12(3):252-8. doi: 10.5144/0256-4947.1992.252. PMID: 17589176.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries